Herpes Zoster
📧 Sign up to get email alerts when something new happens for Herpes Zoster.
Sign up freeTop drugs studied for this disease
-
EMA withdrawal · 2025-06-11EMA Withdrawn: Zostavax (varicella-zoster virus (live, attenuated)) — Merck Sharp & Dohme B.V.
The European Medicines Agency withdrew Zostavax, a live attenuated varicella-zoster vaccine, from the EU market. The decision date was 30 Ju…
-
CLINICAL_TRIALS withdrawal · 2015-08-13Clinical Trial Update: A Lot-to-Lot Consistency Study to Evaluate Safety, Tolerability, and Immunogenicity of Inactivated Varicella Zoster Virus (VZV) Vaccine in Healthy Adults (V212-014) [Phase 3]
A Phase 3 lot-to-lot consistency study of an inactivated Varicella Zoster Virus vaccine in healthy adults has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-03-01Clinical Trial Update: Prevention of Varicella Zoster Virus (VZV)-Reactivation in HIV-positive Individuals Enrolled in a Prospective Immunogenicity and Safety Trial of VZV Vaccine: PROVE-IT-Study [Phase 1, Phase 2]
A Phase 1/2 trial evaluating a Varicella Zoster Virus vaccine to prevent reactivation in HIV-positive individuals has been withdrawn.